No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
93 |
4. Check minimum number of eventsNone |
93 |
5. Include endpointsNone |
93 |
6. Filter based on genotype QC (FinnGen only) |
93 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF6v3
Similar endpoints
↥List of similar endpoints to
Congenital malformation of biliary tract
based on the number of shared cases.
Similar with more cases:
- Congenital malformations of gallbladder, bile ducts and liver
- Other congenital malformations of the digestive system
- Congenital malformations, deformations and chromosomal abnormalities
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 598 | 347 | 248 |
| Only index persons | 436 | 264 | 172 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.01 | 0.01 |
| Only index persons | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 24.75 | 29.19 | 17.94 |
| Only index persons | 42.30 | 43.81 | 39.98 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 93 | 56 | 37 |
| Unadjusted period prevalence (%) | 0.02 | 0.02 | 0.02 |
| Median age at first event (years) | 7.05 | 7.82 | 5.90 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
No data
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 78
- Matched controls
- 781
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q44.21
ICD-10 Finland
Atresia of extrahepatic bile ducts
+∞
36.3
32
*
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
114.5
36.0
37
6
K83.0
ICD-10 Finland
Cholangitis
281.5
34.8
33
*
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
176.9
32.6
32
*
Q44.29
ICD-10 Finland
Atresia of bile ducts
+∞
31.4
28
*
JKD50
NOMESCO Finland
Hepatoportoenterostomy
+∞
31.4
28
*
A05AA02
ATC
ursodeoxycholic acid; oral
106.1
30.8
32
5
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
88.5
30.0
32
6
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
38.4
27.6
35
16
Z94.4
ICD-10 Finland
Liver transplant status
340.3
25.2
24
*
TBW99
NOMESCO Finland
Other minor procedure in endocrine surgery
32.8
24.3
32
16
127
Kela drug reimbursment
Transplant complication
54.5
22.5
26
7
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
12.9
22.5
49
90
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
88.1
18.7
20
*
Q44.4
ICD-10 Finland
Choledochal cyst
+∞
18.5
17
*
L04AX01
ATC
azathioprine; systemic
27.6
18.4
25
13
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
15.5
17.5
30
30
Q44.20
ICD-10 Finland
Atresia of intrahepatic bile ducts
+∞
17.3
16
*
JAH00
NOMESCO Finland
Laparotomy
40.2
17.2
21
7
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
22.5
16.6
24
15
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
+∞
16.2
15
*
JCA32
NOMESCO Finland
Endoscopic injection in oesophagus
198.1
16.1
16
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
8.1
15.8
45
112
A11CC03
ATC
alfacalcidol; systemic
32.9
15.6
20
8
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
18.7
15.5
24
18
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
+∞
15.1
14
*
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
53.3
14.8
17
*
H02AB04
ATC
methylprednisolone; systemic
12.9
14.2
26
29
WX302
NOMESCO Finland
Thoracal epidural anesthesy
21.9
13.9
20
12
L04AD01
ATC
ciclosporin; systemic
28.7
13.6
18
8
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
8.8
13.5
32
57
Z94.0
ICD-10 Finland
Kidney transplant status
39.5
13.2
16
5
Q44.1
ICD-10 Finland
Other congenital malformations of gallbladder
+∞
12.9
12
*
Q44.3
ICD-10 Finland
Congenital stenosis and stricture of bile ducts
+∞
12.9
12
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
14.6
12.5
21
19
H02AB09
ATC
hydrocortisone; systemic
14.6
12.5
21
19
JJ9AE
NOMESCO Finland
Ultrasound examination of liver transplant
+∞
11.7
11
*
JJC00
NOMESCO Finland
Allogenic transplantation of liver
+∞
11.7
11
*
WX408
NOMESCO Finland
General anesthesy, balanced
5.5
11.5
49
183
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
14.4
11.3
19
17
K83.1
ICD-10 Finland
Obstruction of bile duct
51.3
11.3
13
*
TPH07
NOMESCO Finland
Cathetrisation of artery
7.0
11.0
30
64
XF602
NOMESCO Finland
Bloodpressure monitoring
22.8
10.8
15
8
K83.8
ICD-10 Finland
Other specified diseases of biliary tract
+∞
10.7
10
*
K00.81
ICD-10 Finland
Color changes in the teeth caused by biliary anomalies
+∞
10.7
10
*
Q44.0
ICD-10 Finland
Agenesis, aplasia and hypoplasia of gallbladder
+∞
10.7
10
*
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
7.8
10.6
26
47
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
10.2
10.5
21
27
R17
ICD-10 Finland
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
30.7
10.2
13
5
JJC10
NOMESCO Finland
Allogenic partial transplantation of liver
113.2
9.6
10
*
BE00A
NOMESCO Finland
NA
+∞
9.6
9
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
4.7
9.4
44
169
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
11.7
9.4
17
18
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
42.1
9.3
11
*
R50.9
ICD-10 Finland
Fever, unspecified
4.8
9.1
37
123
TPH04
NOMESCO Finland
Cathetrisation of vein
5.1
9.0
33
98
UJK02
NOMESCO Finland
ERCP
56.6
8.9
10
*
JJA20
NOMESCO Finland
Open biopsy of liver
100.5
8.6
9
*
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
100.5
8.6
9
*
5AB14
NOMESCO Finland
NA
100.5
8.6
9
*
WX402
NOMESCO Finland
General anaesthesia
4.4
8.6
39
143
JK3AN
NOMESCO Finland
Biliary tract isotope imaging
+∞
8.5
8
*
R4110
NOMESCO Finland
Physiotherapy
4.1
8.2
43
178
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.8
8.1
30
89
C03DA01
ATC
spironolactone; oral
8.0
8.0
18
28
RD210
NOMESCO Finland
NA
6.9
7.9
20
37
K03.66
ICD-10 Finland
Tooth plaque
5.4
7.8
25
63
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
10.0
7.7
15
18
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
4.8
7.5
27
77
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
5.7
7.4
22
50
JJ5AT
NOMESCO Finland
NA
+∞
7.4
7
*
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
33.4
7.3
9
*
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
15.7
7.1
11
8
L04AA06
ATC
mycophenolic acid; systemic
15.7
7.1
11
8
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
7.8
7.1
16
25
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
18.8
6.9
10
6
L04AA01
ATC
[U] ciclosporin; systemic
44.0
6.9
8
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
10.7
6.6
12
13
K00.40
ICD-10 Finland
Postnatal enamel hypoplasia
8.9
6.4
13
17
602
Kela drug reimbursment
Children's severe malnutrition
6.7
6.4
16
29
V03AG01
ATC
sodium cellulose phosphate; systemic
29.3
6.4
8
*
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
+∞
6.3
6
*
Q44.5
ICD-10 Finland
Other congenital malformations of bile ducts
+∞
6.3
6
*
WX882
NOMESCO Finland
High dependency care
4.5
6.3
23
66
ZX120
NOMESCO Finland
Intravenous
5.7
6.1
17
36
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
44
11
75.02
76.20
4.5
6.9
26.60
36.43
u/ml
0.09
44
11
40
15
46.04
61.41
9.4
2.5
20.97
29.27
umol/l
1.92
40
15
76
109
33.67
61.02
38.1
5.9
11.82
5.99
umol/l
1.97
76
90
42
21
35.65
58.18
17.2
3.5
95.10
91.00
%
0.28
42
21
27
11
34.18
39.36
6.1
3.8
—
—
—
0
0
48
65
14.19
37.44
15.5
5.9
179.96
170.80
%
0.42
48
65
49
86
10.93
30.59
17.7
9.9
107.35
88.86
%
3.91
49
86
28
9
43.59
23.13
3.5
1.8
—
—
—
0
0
60
175
7.84
22.21
7.1
3.5
—
—
—
0
0
76
284
10.17
21.69
28.5
8.3
35.48
36.34
g/l
0.63
76
277
56
159
7.34
21.09
14.2
4.5
1.88
2.15
mg/l
0.08
49
129
59
180
7.23
20.48
5.8
3.9
0.51
0.59
e6/l
0.19
47
116
29
42
9.58
20.40
3.8
4.1
3.75
12.53
ug/l
0.85
21
32
58
176
7.10
20.18
5.8
4.3
2.12
1.65
e6/l
0.20
48
114
30
46
9.15
20.13
3.1
2.3
—
—
—
0
0
43
98
7.30
20.12
7.0
3.2
17.32
20.50
%
0.78
43
93
30
47
8.95
19.75
3.1
2.2
249.17
123.17
u/ml
1.59
23
18
33
62
7.70
18.42
6.3
3.5
59.64
29.90
u/l
1.05
28
52
43
106
6.69
18.36
6.9
3.0
2.64
2.50
g/l
0.77
43
100
28
48
7.92
16.87
4.0
1.9
—
—
—
0
0
44
124
5.84
15.93
7.1
2.9
11.95
13.11
umol/l
0.40
44
116
55
191
5.60
15.54
24.5
9.1
23.85
23.58
mmol/l
0.46
55
186
57
209
5.46
14.95
26.4
9.7
0.78
1.10
mmol/l
0.39
57
158
64
267
5.48
14.09
9.3
4.4
0.05
0.34
e6/l
2.28
58
204
67
294
5.57
13.75
8.0
4.3
—
—
—
0
0
54
200
5.05
13.71
35.6
10.2
1.30
1.35
mmol/l
0.84
54
195
66
302
5.08
12.42
9.8
4.7
—
—
—
0
0
17
24
8.44
11.85
2.9
1.8
—
—
—
0
0
55
230
4.41
11.39
38.2
13.6
24.47
24.74
mmol/l
0.31
55
230
78
436
5.89
10.66
44.9
12.6
1.22
1.23
mmol/l
0.66
78
400
20
44
5.52
9.10
3.7
3.5
72.40
68.95
ml/min/173m2
—
5
19
63
343
3.59
7.89
6.3
4.0
0.00
0.00
estimate
—
8
53
11
15
8.18
7.73
1.1
1.2
—
—
—
0
0
62
340
3.47
7.56
9.8
5.6
0.00
0.00
estimate
—
8
54
62
341
3.45
7.50
6.3
4.0
0.00
0.00
estimate
—
7
55
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
15
30
5.77
7.47
21.7
27.1
0.28
0.34
u/ml
—
10
22
11
7
17.57
7.43
1.1
1.0
—
—
—
0
0
17
39
5.11
7.31
20.7
20.8
24.41
23.72
mmol/l
0.31
17
39
13
23
6.41
7.29
2.4
10.7
40.90
543.93
g/mol
0.63
13
18
10
13
8.50
7.26
1.0
1.0
1.51
1.31
g/l
—
10
13
19
49
4.62
7.12
18.2
17.7
0.81
0.70
%
0.31
19
49
19
49
4.62
7.12
18.5
17.7
1.44
1.19
%
0.45
19
49
11
8
15.36
7.09
1.1
1.3
—
—
—
0
0
11
8
15.36
7.09
1.1
1.3
—
—
—
0
0
11
8
15.36
7.09
1.1
1.3
—
—
—
0
0
11
8
15.36
7.09
1.1
1.3
—
—
—
0
0
11
8
15.36
7.09
1.1
1.3
—
—
—
0
0
59
323
3.26
7.04
6.7
3.3
52.77
75.10
ug/l
1.22
59
305
13
25
5.88
6.70
17.0
20.0
72.66
73.51
%
0.05
13
25
11
18
6.80
6.59
1.1
1.3
—
18.34
—
0
5
30
117
3.31
6.25
2.9
2.2
—
—
—
0
0
26
94
3.45
6.09
3.0
2.3
—
—
—
0
0
26
96
3.37
5.88
2.5
2.1
—
—
—
0
0
77
527
3.68
5.75
32.9
11.7
3.25
3.79
e9/l
1.95
70
437
13
29
5.05
5.71
1.9
1.4
—
—
—
0
0
17
48
4.11
5.63
22.8
16.0
118.94
126.63
g/l
0.55
17
48
16
44
4.18
5.48
1.8
1.6
—
—
—
0
0
44
227
2.78
5.48
30.8
10.4
1.19
1.28
mmol/l
0.11
35
163
10
18
6.10
5.45
1.3
1.2
—
—
—
0
0
11
22
5.54
5.41
1.1
1.4
—
—
—
0
0
11
23
5.29
5.16
2.2
1.3
—
—
—
0
0
14
38
4.16
4.85
1.9
1.8
—
—
—
0
0
11
25
4.86
4.70
1.2
1.2
—
—
—
0
0
15
44
3.87
4.69
20.5
14.8
1.56
1.22
%
0.52
15
44
14
42
3.75
4.24
14.6
8.1
22.81
23.90
mmol/l
1.00
14
37
11
28
4.32
4.11
2.4
1.4
—
—
—
0
0
11
29
4.17
3.93
2.3
2.0
—
—
—
0
0
12
34
3.90
3.91
11.9
9.1
24.84
24.59
mmol/l
0.06
12
34
12
38
3.48
3.35
16.7
4.4
1.24
1.23
mmol/l
0.25
12
33
12
38
3.48
3.35
4.0
2.1
—
—
—
0
0
12
39
3.38
3.22
5.8
2.2
—
—
—
0
0
11
35
3.43
3.04
2.2
2.0
—
—
—
0
0
5
5
10.46
3.01
2.2
1.2
—
—
—
0
0
11
36
3.33
2.91
1.4
1.6
—
—
—
0
0
11
36
3.33
2.91
1.4
1.6
—
—
—
0
0
8
19
4.50
2.74
1.0
1.2
—
—
—
0
0
10
32
3.38
2.73
2.0
2.3
—
—
—
0
0
8
20
4.27
2.63
1.0
1.2
—
—
—
0
0
5
7
7.46
2.58
1.2
1.0
—
—
—
0
0
7
16
4.64
2.52
1.1
1.2
—
—
—
0
0
10
34
3.18
2.50
12.5
11.4
58.01
58.86
%
—
10
34
5
8
6.52
2.40
1.0
1.1
—
—
—
0
0
8
23
3.70
2.33
2.0
4.0
134.00
44.57
u/ml
—
8
23
6
13
4.85
2.31
4.8
2.6
53.67
53.62
%
—
6
13
7
18
4.11
2.30
11.4
3.9
18.04
18.71
%
—
7
8
64
494
1.95
2.28
10.6
4.7
38.12
39.20
mmol/mol
0.29
64
466
58
436
1.88
2.21
30.3
11.7
88.76
87.07
ml/min/173m2
0.15
45
321
86
757
2.81
2.21
77.8
18.5
14.20
13.49
%
3.53
86
750
6
14
4.50
2.19
1.7
1.3
90.50
104.36
%
—
6
14
11
45
2.64
2.01
1.6
1.4
—
—
—
0
0
8
27
3.14
1.99
2.0
1.7
—
—
—
0
0
8
28
3.03
1.91
1.5
2.2
—
—
—
0
0
5
12
4.34
1.84
1.2
1.2
87.20
93.00
%
—
5
12
5
13
4.00
1.74
2.0
1.1
—
—
—
0
0
76
658
1.85
1.47
3.7
3.7
—
—
—
0
0
10
46
2.32
1.46
1.0
1.8
—
—
—
0
0
6
25
2.49
1.26
1.2
4.6
3.45
3.51
mmol/l
—
6
25
8
38
2.21
1.22
1.0
1.2
—
—
—
0
0
9
50
1.88
1.00
3.7
4.4
—
—
—
0
0
19
127
1.62
0.98
7.5
3.7
32.24
12.98
mg/mmol
0.39
14
80
6
27
2.30
0.95
1.2
5.0
241.17
400.63
mg/l
—
6
27
30
225
1.49
0.95
6.7
3.8
—
—
—
0
0
0
25
0.00
0.80
0.0
1.4
—
—
—
0
0
11
67
1.73
0.79
1.7
1.3
—
—
—
0
0
5
28
1.83
0.67
1.2
3.7
21.00
24.18
%
—
5
28
5
30
1.70
0.62
1.4
3.5
—
—
—
0
0
0
21
0.00
0.61
0.0
1.5
—
0.96
—
0
13
24
193
1.33
0.50
2.2
1.8
99.90
95.38
pmol/l
0.17
12
97
7
50
1.43
0.46
1.7
2.6
8.60
5.64
ug/l
—
7
45
0
16
0.00
0.41
0.0
1.6
—
—
—
0
0
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
0
19
0.00
0.39
0.0
1.0
—
81.37
—
0
19
5
36
1.41
0.39
3.2
4.1
0.00
0.15
e6/l
—
5
36
20
165
1.27
0.35
8.1
4.2
0.00
0.00
estimate
—
8
51
5
72
0.68
0.27
1.0
1.0
3.12
3.43
kpa
—
5
55
5
73
0.67
0.27
1.0
1.0
7.24
7.43
kpa
—
5
56
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
6
47
1.30
0.21
1.2
1.6
—
—
—
0
0
0
14
0.00
0.20
0.0
3.1
—
—
—
0
0
6
50
1.21
0.20
8.7
4.9
35.60
23.70
nmol/l
—
6
50
7
58
1.22
0.18
1.4
1.7
—
—
—
0
0
11
92
1.22
0.17
3.0
2.7
2.52
2.46
mmol/l
0.97
11
80
11
93
1.21
0.15
1.1
1.5
111.36
275.27
u/ml
0.67
11
87
30
280
1.11
0.12
1.9
2.1
—
—
—
0
0
6
55
1.10
0.09
8.7
8.6
—
—
—
0
0
16
165
0.96
0.00
3.8
3.7
15.82
26.21
ng/l
1.27
11
110
0
5
0.00
0.00
0.0
1.0
—
9.76
—
0
5
0
5
0.00
0.00
0.0
6.6
—
197.14
—
0
5
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
4.0
—
65.80
—
0
5
0
5
0.00
0.00
0.0
1.8
—
0.60
—
0
5
9
95
0.94
0.00
1.1
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
7
79
0.88
0.00
2.9
2.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
5
50
1.00
0.00
1.2
1.2
—
—
—
0
0
8
86
0.92
0.00
2.9
2.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
25.32
—
0
6
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
5
53
0.94
0.00
1.0
1.5
—
—
—
0
0
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint Q17_CONGEN_MALFO_BILI and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have Q17_CONGEN_MALFO_BILI.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: Q17_CONGEN_MALFO_BILI – Congenital malformation of biliary tract
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data